Physician

Scott Alan Ross, MD

According to 2025 Medicare claims, Scott Ross, MD (NPI: 1205829447) practices dermatology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is NAPLES DERMATOLOGY PA (NPI: 1104006030; TIN: 650330409) and primary practice location at 34103-8702.

Ross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,447 traditional Medicare patients, billed 16,881 HCPCS/CPT codes, and received $1,318,569 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 556 prescription claims across 283 beneficiaries totaling $11,914 in drug costs, led by Metronidazole (Metronidazole). Open Payments data shows 1 records totaling $20. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $24,881 to $11,914. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$682K$1.4M2015 Medicare payment: $1,284,778 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,363,662 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,215,253 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,203,504 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,196,067 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,043,781 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,319,587 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,102,356 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,068,871 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,318,569 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,51819,722$1,284,778
20161,52920,746$1,363,662
20171,46618,570$1,215,253
20181,40118,058$1,203,504
20191,41817,792$1,196,067
20201,31315,357$1,043,781
20211,33016,807$1,319,587
20221,36415,788$1,102,356
20231,40915,373$1,068,871
20241,44716,881$1,318,569

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$25K2015 Drug cost: $24,881 (USD; Tot_Drug_Cst)2016 Drug cost: $21,116 (USD; Tot_Drug_Cst)2017 Drug cost: $20,818 (USD; Tot_Drug_Cst)2018 Drug cost: $15,599 (USD; Tot_Drug_Cst)2019 Drug cost: $13,869 (USD; Tot_Drug_Cst)2020 Drug cost: $12,805 (USD; Tot_Drug_Cst)2021 Drug cost: $11,892 (USD; Tot_Drug_Cst)2022 Drug cost: $11,549 (USD; Tot_Drug_Cst)2023 Drug cost: $12,936 (USD; Tot_Drug_Cst)2024 Drug cost: $11,914 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015210394$24,881
2016208373$21,116
2017236430$20,818
2018260460$15,599
2019222414$13,869
2020218442$12,805
2021225422$11,892
2022227429$11,549
2023265470$12,936
2024283556$11,914

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth7861,200$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,1051,590$65
17000Destruction of precancer skin growth, 1 growth687854$37
88305Pathology examination of tissue using a microscope, intermediate complexity9092,817$29
17003Destruction of precancer skin growth, 2-14 growths5633,480$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MetronidazoleMetronidazole511,532$2,558
Clobetasol PropionateClobetasol Propionate621,462$1,974
Doxycycline HyclateDoxycycline Hyclate581,598$1,654
FluocinonideFluocinonide451,253$1,311
Triamcinolone AcetonideTriamcinolone Acetonide802,388$797

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$20SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Scott Alan Ross, MD?

Tedicare shows public-source Medicare data for Scott Alan Ross, MD (NPI 1205829447), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott Alan Ross, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott Alan Ross, MD?

Scott Alan Ross, MD is linked to NAPLES DERMATOLOGY PA (billing NPI 1104006030) in the available physician profile data.

Does Scott Alan Ross, MD have Open Payments data?

Scott Alan Ross, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.